New Market Research On Global Insomnia Market 2026 | Top Key Players: Group, Monterey Bay Spice Co. Inc., Sun Impex International Foods L.L.C., Indian Organic Farmers Producer Co. Ltd., Sino-Nature International Co. Ltd., Atmiya International, Buderim Group Ltd., Food Market Management Inc., and SA Rawther Spices Pvt. Ltd.
A latest
research report titled as “Insomnia
Market
- Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 -
2026” has been recently added to the vast
portfolio of Market Research Reports Search Engine (MRRSE) online research
offerings. This report is a professional and in-depth analysis on the present
state and future prospect for the global market. It provides valuable
information to the industry insiders, potential entrants or investors. It
includes an exhaustive enquiry with the reliability of logic and the
comprehensiveness of contents.
Prevalence of insomnia has recorded a tremendous
surge in the recent past, however development of an effective treatment
procedure for insomnia has not yet been realized. In order to improve insomnia
therapeutics, there has been an increasing emphasis on developing novel
sleep-inducing medical devices along with new technologies.
Medical device manufacturers are therefore
increasingly concentrating on developing smart & efficient wearable
sleep-inducers with the help of advanced technologies to offer effective
breathing exercises, which in turn enable patients in sleep initiation. Such
devices work in conjunction with smartphone applications and are designed
specifically to enable patients in falling asleep relatively faster, and
staying in their sleep for sufficient amount of time.
Development of New
Drug Formulations to Remain Key Strategy among Pharmaceutical Industries
Increasing efficiency of drugs, which is mainly
attributed to growing bioavailability of these drugs, are likely to enhance
insomnia therapeutics in the upcoming years. Development of new drug
formulations for improving effectiveness of drugs is anticipated to remain a
key strategy among pharmaceutical industries. Although there are several drugs
available in the market for treatment of insomnia, prolonged use of majority of
these drugs has been associated with dependency and addiction. This has further
necessitated the requirement of treatment under medical supervision. Growing
geriatric population is expected to remain a key factor driving demand for
insomnia treatment. In addition, mounting incidences of mental disorders along
with rising stress levels among the urban population has further created demand
for insomnia therapeutics.
Insomnia prevails as the most common sleep
disorder, affecting nearly 35% of the population worldwide. Cases of insomnia
are categorized based on etiology into primary and comorbid subtypes. The
global insomnia market is highly fragmented, along with entry barriers for new
players in terms of product efficacy, innovation, and cost. However, insomnia
therapeutics center on commonly available low-dose sedating antidepressants and
Nonbenzodiazepines, despite introduction of several novel agents, mainly
because of low awareness among patients.
The global market for insomnia will register an
impressive growth during the period 2017 to 2026, according to Market Research
Reports Search Engine (MRRSE) new report. Revenues from the market will reach
roughly US$ 4,000 Mn by 2026-end.
North America to
Remain Most Lucrative Market for Insomnia
North America accounts for the highest percentage
of insomnia-affected patients. For example, according to the Centers for
Disease Control and Prevention (CDC), approximately 70 Mn adults suffered from
insomnia in the United States in 2016, with the male population affected being
relatively higher. Increasing healthcare spending, and surging prevalence of
sleep disorders will create avenues for insomnia therapeutics in the region.
North America is expected to remain the most lucrative market for insomnia, with
sales exhibiting the highest CAGR through 2026.
Asia-Pacific excluding Japan (APEJ) will also
remain a remunerative region for growth of the insomnia market. The market
expansion in APEJ can be highly attributed to increased stress level of working
population along with shift-work related sleep disorders. Governments in the
region are constantly focusing on improving their healthcare system along with
the provision of favorable reimbursement policies, which in turn might impact
the insomnia market in APEJ.
Key Research
Findings
·
Benzodiazepines will remain preferred
treatment for insomnia globally
·
Based on sales channels, retail
pharmacies and drug stores will remain leading revenue contributor to the
market
Competition
Tracking
Although few players in the global insomnia market
offer branded drugs, cost sensitivity prevails as a major challenge in most of
the countries worldwide. Drug manufacturers are therefore focusing on the
development of new cost-effective chemical entities & novel molecules for
boosting their sales and obtaining larger market revenue share. Key companies
profiled by MRRSE report include Pernix Therapeutics Holdings, Inc., Paratek
Pharmaceuticals, Inc., Sumitomo Dainippon Pharma Co., Ltd., Teva Pharmaceutical
Industries Limited, Vanda Pharmaceuticals Inc., Takeda Pharmaceutical Company
Limited, Pfizer Inc., Sanofi, Merck & Co Company, and Mylan N.V.
Market Research
Reports Search Engine (MRRSE) is an industry-leading database of Market
Research Reports. MRRSE is driven by a stellar team of research experts and
advisors trained to offer objective advice. Our sophisticated search algorithm
returns results based on the report title, geographical region, publisher, or
other keywords.
MRRSE partners exclusively with
leading global publishers to provide clients single-point access to
top-of-the-line market research. MRRSE’s repository is updated every day to
keep its clients ahead of the next new trend in market research, be it
competitive intelligence, product or service trends or strategic consulting.
Contact Us
State Tower
90, State Street
Suite 700
Albany, NY – 12207(United State)
Telephone: +1-518-730-0559(US, Canada toll free no)
Email: sales@mrrse.com
Website: https://www.mrrse.com/
Comments
Post a Comment